MCID: RNV001
MIFTS: 46

Renovascular Hypertension malady

Category: Cardiovascular diseases

Aliases & Classifications for Renovascular Hypertension

About this section

Aliases & Descriptions for Renovascular Hypertension:

Name: Renovascular Hypertension 11 13
Hypertension, Renovascular 37 66
 
Hypertension Renovascular 48

Classifications:



External Ids:

Disease Ontology11 DOID:1591
ICD1028 I15.0
MeSH37 D006978
NCIt43 C85044

Summaries for Renovascular Hypertension

About this section
Wikipedia:69 Renovascular hypertension (or \"renal hypertension\") is a condition in which high blood pressure is... more...

MalaCards based summary: Renovascular Hypertension, also known as hypertension, renovascular, is related to antiphospholipid syndrome and malignant renovascular hypertension. An important gene associated with Renovascular Hypertension is REN (Renin), and among its related pathways are Endothelin and Validated transcriptional targets of AP1 family members Fra1 and Fra2. The drugs fenoldopam and fenoldopam mesylate have been mentioned in the context of this disorder. Affiliated tissues include kidney, endothelial and heart, and related mouse phenotypes are liver/biliary system and reproductive system.

Related Diseases for Renovascular Hypertension

About this section

Diseases in the Renovascular Hypertension family:

Benign Renovascular Hypertension Malignant Renovascular Hypertension

Diseases related to Renovascular Hypertension via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 165)
idRelated DiseaseScoreTop Affiliating Genes
1antiphospholipid syndrome30.6ACE, REN
2malignant renovascular hypertension12.3
3benign renovascular hypertension12.2
4hypotelorism cleft palate hypospadias10.7ACE, REN
5atrial septal defect 7, with or without av conduction defects10.7ACE, REN
6chronic granulomatous disease10.7NPPB, REN
7repetitive motion disorders10.6NPPA, REN
8panophthalmitis10.6EDN1, REN
9achromatopsia10.6NPPA, REN
10voyeurism10.6ACE, REN
11diabetic autonomic neuropathy10.6NPPB, REN
12uterine inflammatory disease10.6EDN1, REN
13iga glomerulonephritis10.6EDN1, REN
14blue drum syndrome10.6EDN1, REN
15nephrosclerosis10.6
16marchiafava bignami disease10.6ACE, NPPB
17plasmodium falciparum malaria10.6EDN1, NPPA
18acute liver failure10.5NPPA, REN
19autonomic neuropathy10.5ACE, NPPB
20plica syndrome10.5ACE, REN
21aphthous stomatitis10.5ACE, NPPB
22uniparental disomy of chromosome 1110.4EDN1, NPPB
23hypodermyasis10.4ACE, NPPA, REN
24renal tubular dysgenesis10.4ACE, REN
25benign hypertensive renal disease10.4ACE, NPPB
26benign neonatal seizures10.4ACE, REN
27endotheliitis10.4
28silver-russell syndrome due to 7p11.2p13 microduplication10.4EDN1, NPPA, REN
29burns10.4ACE, SOD1
30islet cell tumor10.4ACE, NOS3
31gonococcal endophthalmia10.4NOS3, NPPB
32degenerative myopia10.4ACE, EDN1, REN
33adenocarcinoma10.4ACE, REN
34trochlear nerve neoplasm10.4ACE, NF1
35pseudomarfanism10.4ACE, NPPA, NPPB
36bladder neck cancer10.4NPPA, NPPB, REN
37littre gland carcinoma10.4ACE, NPPA, REN
38transient refractive change10.4EDN1, NOS3
39hepatocellular adenoma10.4ACE, NOS3
40todd's paralysis10.4ACE, NPPA, NPPB
41fibromuscular dysplasia10.3
42mononeuritis10.3ACE, EDN1, REN
43urinary bladder cancer10.3NOS3, NPPA
44common wart10.3ACE, EDN1, REN
45collecting duct carcinoma10.3ACE, REN
46thrombocytopenia due to platelet alloimmunization10.3EDN1, NOS3
47cystinosis10.3ACE, REN
48corpus luteum cyst10.2EDN1, NOS3
49aneurysm10.2
50takayasu arteritis10.2

Graphical network of the top 20 diseases related to Renovascular Hypertension:



Diseases related to renovascular hypertension

Symptoms for Renovascular Hypertension

About this section

Drugs & Therapeutics for Renovascular Hypertension

About this section

Drugs for Renovascular Hypertension (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 12)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
CandesartanPhase 3153139481-59-72541
Synonyms:
139481-59-7
2-(ethyloxy)-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid
2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid
2-Ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid
2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid
2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid
2-Ethoxy-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl] methyl]-3H-benzoimidazole-4-carboxylic acid
2-ethoxy-1-({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl)-1H-benzimidazole-7-carboxylic acid
2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid
2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl}-1H-benzimidazole-7-carboxylic acid
2-ethoxy-3-[[4-[2-(1h-tetrazol-5-yl)phenyl]phenyl]methyl]-3h-benzoimidazole-4-carboxylic acid
2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid
2-ethoxy-7-carboxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methylbenzimidazole
AC-203
AC1L1DWT
Amias
Atacand
Atacand, Blopress, Amias, Ratacand,Candesartan
BIDD:GT0350
Blopress
Blopress (TN)
C07468
C081643
C24H20N6O3
CHEBI:216848
 
CHEBI:3347
CHEMBL1016
CID2541
CV 11974
CV-11974
CV11974
Candesartan (USAN/INN)
Candesartan [BAN]
Candesartan [USAN:INN]
Candesartan cilexetil
D00522
DB00796
FT-0083585
HMS2089M22
HSDB 7520
I01-0374
KS-5003
L000156
LS-32740
MolPort-003-845-570
MolPort-005-943-739
NCGC00167474-01
Ratacand
S1578_Selleck
TL8000897
UNII-S8Q36MD2XX
candesartan
2
AmlodipinePhase 346488150-42-92162
Synonyms:
()-Amlodipine
(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
-3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydropyridine
2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)
3,5-Pyridinedicarboxylic acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester
3,5-Pyridinedicarboxylic acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester
3-Ethyl 5-methylester, (┬▒)-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl ( -)-2-((2-aminoethoxy)methyl)-4-(2-chlorphenyl)-1,4-dihydro-6-methyl-3,5-pyridindicarboxylat
3-Ethyl-5-methyl ( -)-2-((2-aminoethoxymethyl)-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (.+/-.)-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
3-ethyl 5-methyl 2-{[(2-aminoethyl)oxy]methyl}-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
88150-42-9
88150-47-4 (maleate (1:1))
AC-4535
AC1L1D26
AC1Q32ZS
AMLODIPINE BASE
AMVAZ
Ambap88150-42-9
Amlocard
Amlodipine
Amlodipine (INN)
Amlodipine Benzenesulfonate
Amlodipine Besilate
Amlodipine Besylate
Amlodipine Free Base
Amlodipine [INN:BAN]
Amlodipine besilate
Amlodipine besylate
Amlodipine free base
Amlodipino
Amlodipino [Spanish]
Amlodipinum
Amlodipinum [Latin]
Amlodis
Amlopres
Amlor
 
Amvaz
BIDD:GT0810
BRD-A22032524-074-02-4
BRD-A22032524-074-03-2
BSPBio_002727
C06825
CHEBI:2668
CHEMBL1491
CID2162
CPD000469198
Coroval
D07450
DB00381
HMS2052N03
HMS2089H07
I14-0798
Intervask
Istin
KBio3_001947
KBioGR_001643
LS-131183
Lipinox
Lotrel
MLS001401409
MolPort-001-792-963
NCGC00165957-01
NCGC00165957-02
NCGC00165957-03
Norvasc
Norvasc (TN)
Pelmec
R,S)-Amlodipine
Racemic Amlodipine
SAM001246705
SMR000469198
SPBio_000351
Spectrum2_000486
Spectrum3_001004
Spectrum4_001132
Spectrum5_001550
UK-4834011
UNII-1J444QC288
amlodipine
3calcium channel blockersPhase 31889
4
Candesartan cilexetilPhase 3153145040-37-52540
Synonyms:
(+-)-1-Hydroxyethyl 2-ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylate, cyclohexyl carbonate (ester)
1-(cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate
1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-(ethyloxy)-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate
145040-37-5
1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester
2-Ethoxy-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester
2-ethoxy-3-[2'-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3h-benzoimidazole-4-carboxylic acid 1-cyclohe
AC-204
AC1L1DWQ
ATACAND HCT
Almirall brand of candesartan cilexetil
Amias
Astra brand of candesartan cilexetil
AstraZeneca brand of candesartan cilexetil
Atacand
Atacand (TN)
BRD-A65671304-001-02-6
BSPBio_002691
C07709
C077793
C33H34N6O6
CHEBI:216349
CHEMBL1014
CID2540
Candesartan cilexetil
Candesartan cilexetil (JAN/USAN)
Candesartan cilexetil [USAN]
Candesartan hexetil
D00626
FT-0082579
H212/91
 
HMS1922J09
HMS2093E20
I06-0090
KBio2_002187
KBio2_004755
KBio2_007323
KBio3_001911
KBioGR_001607
KBioSS_002187
Kenzen
L006257
LS-32741
MolPort-003-666-552
NCGC00095123-01
NCGC00095123-02
NCGC00095123-03
Parapres
Promed brand of candesartan cilexetil
Racanda
SPBio_000349
SPECTRUM1504261
ST51052687
Spectrum2_000485
Spectrum3_000996
Spectrum4_001124
Spectrum5_001462
Spectrum_001707
TCV 116
TCV-116
TL8000995
Takeda brand of candesartan cilexetil
UNII-R85M2X0D68
candesartan cilexitil
5Atorvastatin CalciumPhase 3727134523-03-8
6
angiotensin IIPhase 3113568521-88-0, 11128-99-7172198, 65143
Synonyms:
1-8-Angiotensin I
1-L-Aspasaginyl-5-L-valyl angiotensin octapeptide
Ang II
Angiotensin 2
Angiotensin II (human)
 
Angiotensin II (mouse)
Angiotonin
Asp-arg-val-TYR-ile-his-pro-phe
Human angiotensin II
Hypertensin
Ile(5)-angiotensin II
7
Spironolactone2171952-01-7, 52-01-75833
Synonyms:
4-18-00-01601 (Beilstein Handbook Reference)
4-Pregnen-21-oic acid-17alpha-ol-3-one-7alpha-thiol gamma-lactone 7-acetate
496916-40-6
52-01-7
7-alpha-Acetylthio-3-oxo-17-alpha-pregn-4-ene-21,17-beta-carbolactone
7alpha-(acetylsulfanyl)-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone
AB00513806
AC-4214
AC1L1L8Q
Abbolactone
Acelat
Aldace
Aldactazide
Aldactide
Aldactone
Aldactone (TN)
Aldactone A
Alderon
Aldopur
Almatol
Alphapharm Brand of Spironolactone
Alpharma Brand of Spironolactone
Alter Brand of Spironolactone
Altex
Aquareduct
Ashbourne Brand of Spironolactone
Azupharma Brand of Spironolactone
BIDD:PXR0071
BPBio1_000194
BRD-K90027355-001-03-4
BRN 0057767
BSPBio_000176
C07310
C24H32O4S
CHEBI:428201
CHEBI:45692
CHEBI:9241
CHEMBL1393
CID5833
CPD000471892
Cardel Brand of Spironolactone
D00443
D013148
DB00421
Deverol
Dexo Brand of Spironolactone
Diatensec
Dira
Duraspiron
EINECS 200-133-6
Espironolactona
Espironolactona Alter
Espironolactona Mundogen
Espironolactona [INN-Spanish]
Euteberol
Flumach
Frumikal
Generosan Brand of Spironolactone
HMS1568I18
HMS2090N21
HSDB 3184
Hormosan Brand of Spironolactone
I06-1970
Jenapharm Brand of Spironolactone
Jenaspiron
LS-118614
LT00772287
Lacalmin
Lacdene
Laractone
MLS001074672
MLS001333253
MLS001333254
MLS002153245
MLS002207058
Mayoly-Spindler Brand of Spironolactone
Melarcon
Merck dura Brand of Spironolactone
Mundogen Brand of Spironolactone
NCGC00164397-01
 
NCGC00164397-02
NSC 150399
NSC150399
Nefurofan
Novo Spiroton
Novo-Spiroton
NovoSpiroton
Novopharm Brand of Spironolactone
Osyrol
Pfizer Brand of Spironolactone
Pharmafrid Brand of Spironolactone
Practon
Prestwick0_000128
Prestwick1_000128
Prestwick2_000128
Prestwick3_000128
Roche Brand of Spironolactone
S0260
S3378_SIGMA
SAM002264648
SC 9420
SC-9420
SC9420
SMR000471892
SNL
SPBio_002115
Sagisal
Searle Brand of Spironolactone
Sincomen
Spiractin
Spiresis
Spiretic
Spiridon
Spiro L.U.T.
Spiro(17H-cyclopenta(a)phenauthrene-17,2'-(3'H)-furan)
Spiro-Tablinen
Spiro[17H-cyclopenta[a]phenauthrene-17,2'-(3'H)-furan]
Spirobeta
Spiroctan
Spiroctanie
Spiroderm
Spirogamma
Spirolactone
Spirolakton
Spirolang
Spirolone
Spirone
Spirono Isis
Spirono-Isis
Spironocompren
Spironolactone
Spironolactone (JP15/USP/INN)
Spironolactone A
Spironolactone [BAN:INN:JAN]
Spironolactone [INN:BAN:JAN]
Spironolactonum
Spironolactonum [INN-Latin]
Spironolattone
Spironolattone [DCIT]
Spironone
Spirospare
Sprioderm
Supra-puren
Suracton
UNII-27O7W4T232
Uractone
Urusonin
Veroshpiron
Verospiron
Verospirone
Verospirone Opianin
WLN: L E5 B666 FX OV MUTJ A1 E1 KSV1 F-& CT5VOXTJ
Worwag Brand of Spironolactone
Xenalon
ZINC03861599
betapharm Brand of Spironolactone
ct Arzneimittel Brand of Spironolactone
ct-Arzneimittel Brand of Spironolactone
spiro von ct
spironolactone
spironolattone
von ct, spiro
8diuretics1338
9
Amiloride502016-88-8, 2609-46-316231
Synonyms:
17440-83-4 (hydrochloride)
1f5l
2016-88-8 (anhydrous hydrochloride)
2609-46-3
3,5-Diamino-N-(aminoiminomethyl)-6-chloropyrazinecarboxamide
3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide
3,5-diamino-6-chloro-N-(diaminomethylidene)pyrazine-2-carboxamide
3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide
3,5-diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide
AB00053415
AC-13631
AC1L27IZ
AC1Q3POC
AMILORIDE
AMILORIDE (SEE ALSO: AMILORIDE HCL (2016-88-8))
Amiclaran
Amiclaran (TN)
Amikal (Hydrochloride dihydrate)
Amilorid
Amilorida
Amilorida [INN-Spanish]
Amiloride (INN)
Amiloride HCL
Amiloride [INN:BAN]
Amiloride hydrochloride hydrate
Amiloridum
Amiloridum [INN-Latin]
Amipramidin
Amipramidine
Amipramizid
Amipramizide
Amiprazidine
Amyloride
BCBcMAP01_000101
BIDD:GT0466
BPBio1_000015
BRD-K97181089-003-02-3
BRD-K97181089-310-03-0
BSPBio_000013
BSPBio_001572
BSPBio_001826
Bio1_000359
Bio1_000848
Bio1_001337
Bio2_000292
Bio2_000772
C06821
C6H8ClN7O
CCRIS 6545
CHEBI:2639
CHEMBL945
CID16231
CPD-10324
D07447
DB00594
DivK1c_000182
EINECS 220-024-7
Guanamprazin
 
Guanamprazine
HMS1791O14
HMS1989O14
HMS2089H05
IDI1_000182
IDI1_034042
KBio1_000182
KBio2_000292
KBio2_000394
KBio2_002860
KBio2_002962
KBio2_005428
KBio2_005530
KBio3_000583
KBio3_000584
KBio3_001326
KBioGR_000292
KBioGR_000544
KBioSS_000292
KBioSS_000394
LS-1094
Lopac-A-7410
Lopac0_000111
MK-870 (Hydrochloride dihydrate)
MLS000758249
MLS001060798
Midamor
Midamor (Hydrochloride dihydrate)
MolPort-005-934-472
MolPort-005-937-651
N-Amidino-3,5-diamino-6-chloropyrazinecarboxamide
N-Amidino-3,5-diamino-6-chlorpyrazincarboxamid
N-amidino-3,5-diamino-6-chloropyrazinecarboxamide
NCGC00015089-01
NCGC00015089-02
NCGC00015089-12
NCGC00024443-02
NCGC00024443-05
NCGC00024443-06
NCGC00024443-07
NCGC00024443-09
NINDS_000182
Prestwick0_000007
Prestwick1_000007
Prestwick2_000007
Prestwick3_000007
Pyrazinecarboxamide, 3,5-diamino-N-(aminoiminomethyl)-6-chloro-, monohydrochloride
SMR000449325
SMR000486264
SPBio_000136
SPBio_001934
ST079279
Spectrum2_000118
Spectrum3_000293
Spectrum4_000132
Spectrum5_000776
Spectrum_000034
Tocris-0890
UNII-7DZO8EB0Z3
ZINC04340269
10
Lidocaine1168137-58-63676
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
AKOS001026768
ARONIS23855
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Alphacaine
Anestacon
Anestacon Jelly
BIDD:GT0342
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
Bio-0767
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
C07073
C14H22N2O
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
CPD000058189
Cappicaine
Cito optadren
Cuivasil
D00358
DB00281
Dalcaine
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla
Emla Cream
Esracaine
FT-0082378
Gravocain
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L-Caine
L0156
L1026_SIGMA
L7757_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
 
LS-805
Lanabiotic
Leostesin
Lida-Mantle
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
Lignocaine
Lignocainum
Lingocaine
Lopac-L-5647
Lopac0_000669
MLS000069724
MLS000758263
MLS001074177
Maricaine
Maybridge1_002571
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
NINDS_000174
NSC 40030
NSC40030
Norwood Sunburn Spray
Octocaine
Octocaine-100
Octocaine-50
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
SPBio_001525
SPBio_002100
STK552033
Solarcaine
Solarcaine aloe extra burn relief cream
Solcain
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
Spectrum_001118
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-MPF
Xylocaine-MPF with Glucose
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
alpha-Diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-dimethylacetanilide
lidocaine
nchembio.65-comp16
╬▒-diethylamino-2,6-dimethylacetanilide
11calcium heparin779
12
Heparin7799005-49-6772, 46507594
Synonyms:
101921-26-0
102-94-3
102785-31-9
104521-37-1
11078-24-3
11129-39-8
12656-11-0
2-o-sulfohexopyranuronosyl-(1->4)-2-deoxy-3-o-sulfo-2-(sulfoamino)hexopyranosyl-(1->4)-2-o-sulfohexopyranuronosyl-(1->4)-2-acetamido-2-deoxy-6-o-sulfohexopyranose
37324-73-5
6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxyoxan-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-3,4-dihydroxy-5-sulfooxyoxane-2-carboxylic acid
9041-08-1
9045-22-1
9075-96-1
913079-23-9
91449-79-5
AC1L19ZN
AC1L1ROY
ALFA 87-120
ALFA 87-163
ALFA 87-198
ALFA 87-81
ALFA 88-247
AR-1E4539
Allocinnamic acid
Ardeparin
Ardeparin sodium
Arteven
Bemiparin
Bemiparin sodium
CID772
CID8784
CY 216
Calciparine
Certoparin
Clexane
Clivarin
Clivarine
Cy 222
D006495
D017984
DB00407
DB01225
Dalteparin
Dalteparin sodium
Depo-Heparin
EINECS 232-681-7
EMT 966
EMT 967
EMT-966
EMT-967
EMT966
EMT967
Enoxaparin
Enoxaparin sodium
Enoxaparine
Eparina
Eparina [DCIT]
FR 860
Fluxum
Fragmin A
Fragmin B
Fragmin IV
Fraxiparin
H 2149
HSDB 3094
Hed-heparin
Hep Flush Kit in plastic container
Hep-Lock
Hep-Lock U/P
Hep-lock
Heparin
Heparin CY 216
Heparin Lock Flush
Heparin Lock Flush in plastic container
Heparin Lock Flush preservative free
Heparin Lock Flush preservative free in plastic container
Heparin Sodium
Heparin natrium
Heparin sodium
Heparin sodium 1,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 1,000 units in dextrose 5% in plastic container
Heparin sodium 1,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 10,000 units in dextrose 5%
Heparin sodium 10,000 units in dextrose 5% in plastic container
Heparin sodium 10,000 units in sodium chloride 0.45%
Heparin sodium 10,000 units in sodium chloride 0.9%
Heparin sodium 12,500 units in dextrose 5%
Heparin sodium 12,500 units in dextrose 5% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.45% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.9%
Heparin sodium 2,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 2,000 units in dextrose 5% in plastic container
Heparin sodium 2,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 20,000 units and dextrose 5% in plastic container
Heparin sodium 20,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units and dextrose 5% in plastic container
 
Heparin sodium 25,000 units in dextrose 5%
Heparin sodium 25,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.45% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.9%
Heparin sodium 25,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units in dextrose 5% in plastic container
Heparin sodium 5,000 units in sodium chloride 0.45%
Heparin sodium 5,000 units in sodium chloride 0.9%
Heparin sodium 5,000 units in sodium chloride 0.9% in plastic container
Heparin sodium in plastic container
Heparin sodium preservative Free
Heparin sulfate
Heparin sulphate
Heparin, Low Molecular Weight
Heparin, Low-Molecular-Weight
Heparin, sodium salt
Heparina
Heparina [INN-Spanish]
Heparinate
Heparine
Heparine [INN-French]
Heparinic acid
Heparinsodiumsalt
Heparinum
Heparinum [INN-Latin]
Heparinum natricum
Hepathrom
Hepflush-10
Inno-Hep
Innohep
Isocinnamic acid
KB 101
Kabi 2165
LHN 1
LMWH
Lioton 1000
Lipo-hepin
Liquaemin
Liquaemin Lock Flush
Liquaemin Sodium
Liquaemin sodium preservative free
Liquemin
Logiparin
Lovenox
Lovenox HP
Low Molecular Weight Heparin
Low molecular weight heparin
Low molecular weight heparin sodium
Low-Molecular-Weight Heparin
Minolteparin sodium
MolPort-003-760-257
Multiparin
NSC174025
Nadroparin
Nadroparine
Novoheparin
OP 386
OP 622
Octaparin
PK 10,169
PK-10,169
PK-10169
PK10,169
PK10169
Pabyrin
Panheprin
Parnaparin
Parnaparin sodium
Parvoparin
Pularin
Reviparin
Reviparin sodium
Ro 11
Sandoparin
Sodium acid heparin
Sodium heparin
Sodium heparinate
Subeparin
Sublingula
Thromboliquine
Tinzaparin
Tinzaparin sodium
Triofiban
UNII-12M44VTJ7B
UNII-3S182ET3UA
UNII-E47C0NF7LV
UNII-T2410KM04A
UNII-ZZ45AB24CA
Unfractionated heparin
Vetren
Vitrum AB
WY 90493RD
alpha-Heparin
cis-.beta.-Carboxystyrene
cis-Cinnamic acid
enoxaparin
heparin

Interventional clinical trials:

(show all 19)
idNameStatusNCT IDPhase
1Revascularization of Renal Artery Stenosis Versus Medical Therapy for the Treatment of Ischemic NephropathyActive, not recruitingNCT01023373Phase 4
2Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic LesionsCompletedNCT00081731Phase 3
3Renal Stenting With Distal Atheroembolic ProtectionRecruitingNCT00868972Phase 2, Phase 3
4Study to Assess the Effects of Intravenous Bendavia in Patients Undergoing Percutaneous Transluminal Angioplasty of the Renal Artery (PTRA)TerminatedNCT01755858Phase 1, Phase 2
5MRI to Detect Embolism Following Angiography and Angioplasty-Stenting of the Renal ArteryCompletedNCT00027469Phase 1
6Hypoxia and Inflammatory Injury in Human Renovascular HypertensionRecruitingNCT02266394Phase 1
7MSC for Occlusive Disease of the KidneyActive, not recruitingNCT01840540Phase 1
8Magnetic Resonance Imaging for Evaluating Kidney FunctionCompletedNCT00006173
9Renal Atherosclerotic Revascularization Evaluation: RAVE StudyCompletedNCT00127738
10REFORM Clinical Study: Treatment of Renal Artery Stenosis With the Formula Balloon-Expandable StentCompletedNCT00631540
11Cross-sectional Study of Patients With Renal or Craniocervical Fibromuscular DysplasiaCompletedNCT02884141
12The Effects of Amiloride and Spironolactone on Renophysiological and Cardiovascular VariablesCompletedNCT01195805
13Telehealth & Remote Measurement Technologies to Improve Medication Adherence in HypertensionCompletedNCT01439256
14A Prospective Danish National Registry of PTRA in Patients With Renovascular HypertensionRecruitingNCT02770066
15Renal Stent Placement for the Treatment of Renal Artery Stenosis in Patients With Resistant HypertensionRecruitingNCT01673373
16Cardiovascular, Renal and Metabolic Profile in Patients With Acute Myocardial Infarction (REN-ACS)RecruitingNCT02388139
17Evaluation of Patients With Heart Disease Not Eligible for Research ProtocolsRecruitingNCT00001458
18IntErnational Long-term Follow-up Study of Patients With Uncontrolled HyperTensioNActive, not recruitingNCT01705080
19A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and Cardiac Ablation on AF RecurrenceActive, not recruitingNCT01907828

Search NIH Clinical Center for Renovascular Hypertension

Inferred drug relations via UMLS66/NDF-RT44:


Cochrane evidence based reviews: hypertension, renovascular

Genetic Tests for Renovascular Hypertension

About this section

Anatomical Context for Renovascular Hypertension

About this section

MalaCards organs/tissues related to Renovascular Hypertension:

34
Kidney, Endothelial, Heart, Testes, Liver, Brain, Monocytes

Animal Models for Renovascular Hypertension or affiliated genes

About this section

MGI Mouse Phenotypes related to Renovascular Hypertension:

39 (show all 12)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053708.3ACE, HMOX1, NF1, NOS3, SERPINC1, SOD1
2MP:00053897.5ACE, HMOX1, NOS3, NPR2, REN, SERPINC1
3MP:00053677.5ACE, EDN1, HMOX1, NF1, NOS3, NPPA
4MP:00053797.3ACE, EDN1, HMOX1, NF1, NOS3, NPR2
5MP:00053697.2EDN1, HMOX1, NF1, NOS3, NPPA, NPR2
6MP:00053877.2ACE, HMOX1, NF1, NOS3, NPR2, REN
7MP:00053867.0ACE, HMOX1, NF1, NOS3, NPR2, REN
8MP:00053786.9ACE, EDN1, HMOX1, NF1, NOS3, NPR2
9MP:00053976.7ACE, HMOX1, NF1, NOS3, NPPA, NPR2
10MP:00107686.6ACE, EDN1, HMOX1, NF1, NOS3, NPR2
11MP:00053856.1ACE, EDN1, HMOX1, NF1, NOS3, NPPA
12MP:00053766.0ACE, EDN1, HMOX1, NF1, NOS3, NPPA

Publications for Renovascular Hypertension

About this section

Articles related to Renovascular Hypertension:

(show top 50)    (show all 641)
idTitleAuthorsYear
1
Management of Renovascular Hypertension. (27641455)
2016
2
The Nuclear Factor kappaB Inhibitor Pyrrolidine Dithiocarbamate Prevents Cardiac Remodelling and Matrix Metalloproteinase-2 Up-Regulation in Renovascular Hypertension. (25816715)
2015
3
Detection of Segmental Renal Ischemia by Diffusion-Weighted Magnetic Resonance Imaging: Clinical Utility for Diagnosis of Renovascular Hypertension. (26360321)
2015
4
Attenuated muscle metaboreflex-induced pressor response during postexercise muscle ischemia in renovascular hypertension. (25632024)
2015
5
Atorvastatin and sildenafil decrease vascular TGF-I^ levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension. (26343345)
2015
6
Renovascular hypertension: A report of 21 cases. (24434389)
2014
7
Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-I^ and MMPs, and decreases vascular remodeling in renovascular hypertension. (23806385)
2013
8
Reproductive dysfunction in female rats with renovascular hypertension. (23382333)
2013
9
Fibromuscular dysplasia causing renal artery aneurysm and renovascular hypertension: a case report. (21341557)
2010
10
The Case: An unusual cause of renovascular hypertension. (19444276)
2009
11
Tissue kallikrein deficiency and renovascular hypertension in the mouse. (19244588)
2009
12
Induction of heme oxygenase-1 in renovascular hypertension is associated with inhibition of apoptosis. (17531161)
2007
13
Diagnosis and management of renovascular disease and renovascular hypertension. (17485974)
2007
14
Two cases of hyponatremic-hypertensive syndrome in childhood with renovascular hypertension. (16411091)
2006
15
Diagnostic and treatment of renovascular hypertension in the patient with horseshoe kidney]. (15909888)
2005
16
Evaluation of vascular function in apolipoprotein E knockout mice with angiotensin-dependent renovascular hypertension. (16087779)
2005
17
Decreased susceptibility to renovascular hypertension in mice lacking the prostaglandin I2 receptor IP. (15372104)
2004
18
Renovascular hypertension: diagnostic and therapeutic challenges. (15055332)
2004
19
Alteration of local ACE activity and vascular responsiveness during development of 2K1C renovascular hypertension. (12591015)
2003
20
Association between altered circadian blood pressure profile and cardiac end-organ damage in patients with renovascular hypertension. (14631131)
2003
21
Renovascular hypertension, endothelial function, and oxidative stress. (12421899)
2002
22
Diagnostic criteria for renovascular hypertension. (12136534)
2002
23
Unilateral stent implantation for renal function in bilateral atherosclerotic renovascular hypertension--a case report. (12025924)
2002
24
The sympathetic nervous system in renovascular hypertension: lead actor or 'bit' player? (12023671)
2002
25
Connexins 40 and 43 are differentially regulated within the kidneys of rats with renovascular hypertension. (11422751)
2001
26
Tuberculous abdominal lymphadenopathy causing reversible renovascular hypertension. (11273151)
2000
27
Evaluation and long-term outcome of pediatric renovascular hypertension. (10975320)
2000
28
Nitric oxide modulates the development and surgical reversal of renovascular hypertension in rats. (10826564)
2000
29
Angiotensin-converting enzyme gene I/D polymorphism and carotid artery disease in renovascular hypertension. (10701811)
2000
30
Renovascular hypertension observed in a patient with antiphospholipid-antibody syndrome. (10929786)
2000
31
Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension. (10406830)
1999
32
Mesangial hyperplasia in a patient with renovascular hypertension and proteinuria. (9794597)
1998
33
Treatment of renovascular disease and of renovascular hypertension. (10048497)
1998
34
Renovascular hypertension may cause nephrotic range proteinuria and focal glomerulosclerosis in contralateral kidney. (9352155)
1997
35
Left ventricular anatomy and function in primary aldosteronism and renovascular hypertension. (9433512)
1997
36
A comparison of outcome criteria in the diagnosis of renovascular hypertension. (8989973)
1996
37
Role of captopril renography in the diagnosis of renovascular hypertension. (8768915)
1996
38
Diagnosis of renovascular hypertension by echo-Doppler velocimetry. (8840548)
1996
39
Increased nitric oxide activity in early renovascular hypertension. (8769793)
1996
40
Pediatric renovascular hypertension. (8723806)
1996
41
A case of renovascular hypertension with marked polyuria after percutaneous transluminal renal angioplasty. (8742962)
1996
42
Percutaneous transluminal angioplasty for renovascular hypertension 9 years after hypoplastic kidney transplantation: report of a case. (8658800)
1996
43
A recent institutional experience with renovascular hypertension. (8607586)
1996
44
Renal effects of antihypertensive agents in parenchymal renal disease and renovascular hypertension. (1382165)
1992
45
Effects of atrial natriuretic factor on patients with renovascular hypertension. (1288975)
1992
46
Aspirin injection test to predict angioplasty outcome in unilateral renovascular hypertension: preliminary report. (1838974)
1991
47
The role of laboratory testing in the diagnosis of renovascular hypertension. (1914198)
1991
48
Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. (6223227)
1983
49
Control of malignant renovascular hypertension by percutaneous transluminal angioplasty and therapeutic renal embolization. (6767370)
1980
50
Changes of plasma renin, angiotensin II and renin substrate during reversal of malignant renovascular hypertension. (1206969)
1975

Variations for Renovascular Hypertension

About this section

Expression for genes affiliated with Renovascular Hypertension

About this section
Search GEO for disease gene expression data for Renovascular Hypertension.

Pathways for genes affiliated with Renovascular Hypertension

About this section

GO Terms for genes affiliated with Renovascular Hypertension

About this section

Cellular components related to Renovascular Hypertension according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular regionGO:00055767.2ACE, EDN1, NPPA, NPPB, REN, SERPINC1
2extracellular spaceGO:00056157.0ACE, EDN1, HMOX1, NPPA, NPPB, REN

Biological processes related to Renovascular Hypertension according to GeneCards Suite gene sharing:

(show all 26)
idNameGO IDScoreTop Affiliating Genes
1beta-amyloid metabolic processGO:005043510.4ACE, REN
2regulation of systemic arterial blood pressure by endothelinGO:000310010.4EDN1, NOS3
3phosphatidylinositol 3-kinase signalingGO:001406510.3EDN1, NF1
4regulation of blood vessel sizeGO:005088010.3NOS3, NPPA
5smooth muscle hyperplasiaGO:001480610.3HMOX1, NOS3
6angiotensin maturationGO:000200310.2ACE, REN
7regulation of vasodilationGO:004231210.2ACE, NPPB
8body fluid secretionGO:000758910.2EDN1, NPPB
9positive regulation of heart rateGO:001046010.1EDN1, NPPA
10cellular response to heatGO:003460510.1HMOX1, NF1
11positive regulation of vasodilationGO:004590910.1HMOX1, NOS3
12blood vessel remodelingGO:000197410.0ACE, NOS3
13regulation of angiogenesisGO:004576510.0HMOX1, NF1
14removal of superoxide radicalsGO:001943010.0NOS3, SOD1
15negative regulation of extrinsic apoptotic signaling pathway via death domain receptorsGO:19020429.9HMOX1, NOS3
16response to muscle stretchGO:00359949.9EDN1, NPPA
17regulation of vasoconstrictionGO:00192299.9ACE, EDN1
18superoxide anion generationGO:00425549.9EDN1, SOD1
19heart contractionGO:00600479.7ACE, SOD1
20cellular response to cadmium ionGO:00712769.7HMOX1, SOD1
21positive regulation of renal sodium excretionGO:00358159.6EDN1, NPPB
22positive regulation of urine volumeGO:00358109.5EDN1, NPPB
23receptor guanylyl cyclase signaling pathwayGO:00071689.3NPPA, NPPB, NPR2
24cGMP biosynthetic processGO:00061829.3NPPA, NPPB, NPR2
25response to hypoxiaGO:00016668.6EDN1, HMOX1, NF1, NPPA
26regulation of blood pressureGO:00082176.6ACE, EDN1, HMOX1, NOS3, NPPA, NPPB

Molecular functions related to Renovascular Hypertension according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1hormone activityGO:00051799.6EDN1, NPPA, NPPB
2receptor bindingGO:00051028.9EDN1, NPPA, NPPB, REN

Sources for Renovascular Hypertension

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
25GTR
26HGMD
27HMDB
28ICD10
29ICD10 via Orphanet
30ICD9CM
31IUPHAR
32KEGG
35MedGen
37MeSH
38MESH via Orphanet
39MGI
42NCI
43NCIt
44NDF-RT
47NINDS
48Novoseek
50OMIM
51OMIM via Orphanet
55PubMed
56QIAGEN
61SNOMED-CT via Orphanet
65Tumor Gene Family of Databases
66UMLS
67UMLS via Orphanet